MwanzoSLN • NASDAQ
add
Silence Therapeutics PLC - ADR
Bei iliyotangulia
$ 5.98
Bei za siku
$ 5.42 - $ 5.99
Bei za mwaka
$ 1.97 - $ 7.78
Thamani ya kampuni katika soko
269.23M USD
Wastani wa hisa zilizouzwa
elfu 215.76
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (GBP) | 2021info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 12.42M | 126.59% |
Matumizi ya uendeshaji wa biashara | 50.77M | 55.27% |
Mapato halisi | -39.41M | -21.09% |
Kiwango cha faida halisi | -317.44 | 46.56% |
Mapato kwa kila hisa | — | — |
EBITDA | -45.56M | -49.44% |
Asilimia ya kodi ya mapato | 14.06% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (GBP) | 2021info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 73.54M | 96.37% |
Jumla ya mali | 96.19M | 11.89% |
Jumla ya dhima | 87.67M | 13.98% |
Jumla ya hisa | 8.53M | — |
hisa zilizosalia | 29.93M | — |
Uwiano wa bei na thamani | 21.36 | — |
Faida inayotokana na mali | -31.44% | — |
Faida inayotokana mtaji | -317.04% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (GBP) | 2021info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -39.41M | -21.09% |
Pesa kutokana na shughuli | 6.81M | 163.16% |
Pesa kutokana na uwekezaji | 8.68M | -9.79% |
Pesa kutokana na ufadhili | 30.71M | 99.06% |
Mabadiliko halisi ya pesa taslimu | 46.09M | 230.76% |
Mtiririko huru wa pesa | -4.96M | 85.46% |
Kuhusu
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
116
